270 related articles for article (PubMed ID: 2970382)
1. [Effect of levamisole on the activity of the blood T-lymphocytes and of factors they produce in patients with laryngeal cancer].
Volosevich LI; Lukach EV; Krivokhatskaia LD
Eksp Onkol; 1988; 10(3):54-7. PubMed ID: 2970382
[TBL] [Abstract][Full Text] [Related]
2. The in vitro effect of levamisole on histamine inhibited E-rosette forming T-lymphocyte subpopulation in patients affected by disseminated erythematosus lupus.
Pozsonyi T; Jakab L; Fehér J; Cseh K
Allergol Immunopathol (Madr); 1982; 10(6):435-9. PubMed ID: 6220589
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures of T and B cells by levamisole in vitro and in vivo.
Hersey P; Ho K; Werkmeister J; Abele U
Clin Exp Immunol; 1981 Nov; 46(2):340-9. PubMed ID: 6461457
[TBL] [Abstract][Full Text] [Related]
4. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
Pozsonyi T; Jakab L; Fehér J
Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
[TBL] [Abstract][Full Text] [Related]
5. Some T-cell functions in patients with viral myocarditis. The effect of levamisole.
Goch JH; Czernicki J; Offierska M
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):395-404. PubMed ID: 6223612
[TBL] [Abstract][Full Text] [Related]
6. Lymphocytes T and pharmacokinetics after a single oral dose of levamisole in healthy and cancer subjects.
Luyckx M; Cazin M; Brunet C; Cazin JC; Devulder B; Gosselin P; Adenis L; Cappelaere P; Granier AM; Demaille A
Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):467-9. PubMed ID: 6608036
[TBL] [Abstract][Full Text] [Related]
7. [Effect of concomitant pathology and radiation treatment on the immunity indices of patients with laryngeal cancer].
Bulbuk GA; Tsybyrné GA; Mazur LN; Dariĭ VA
Vopr Onkol; 1989; 35(5):608-12. PubMed ID: 2741432
[TBL] [Abstract][Full Text] [Related]
8. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
Levo Y; Rotter V; Ramot B
Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
[TBL] [Abstract][Full Text] [Related]
9. [Cellular immunity indices of ovarian cancer patients].
Vinokurov VL; Nikolaeva LIa
Vopr Onkol; 1986; 32(1):60-4. PubMed ID: 2936001
[TBL] [Abstract][Full Text] [Related]
10. [Immune reactivity and in vitro effect of levamisole in a group of patients with malignant melanoma].
Sansoni P; Rossetti A; Valente G; Butturini U
Boll Ist Sieroter Milan; 1982 Mar; 61(1):51-7. PubMed ID: 6982048
[No Abstract] [Full Text] [Related]
11. [Expression of surface markers of lymphocytes and their relation to suppressor function in lymphogranulomatosis].
Tabagari DZ; Chernovskaia EM; Kadagidze ZG
Eksp Onkol; 1985; 7(2):60-4. PubMed ID: 3159562
[TBL] [Abstract][Full Text] [Related]
12. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
13. [Influence of the administration of levamisole on the reactivity of T-lymphocytes in advanced cancer patients].
Renoux G; Renoux M
Nouv Presse Med; 1976 Jan; 5(2):67-70. PubMed ID: 772602
[TBL] [Abstract][Full Text] [Related]
14. Effect of plasmapheresis on cellular immunity abnormalities in patients with systemic lupus erythematosus.
Bonomini V; Vangelista A; Frascà GM; Nanni-Costa A; Borgnino LC
Clin Nephrol; 1984 Sep; 22(3):121-6. PubMed ID: 6237815
[TBL] [Abstract][Full Text] [Related]
15. [Action of levamisole on lymphocytic reactivity in naso-laryngeal carcinoma].
Stivala F; Malannino N; Cordopatri F; Campo M
Boll Soc Ital Biol Sper; 1980 Aug; 56(16):1687-93. PubMed ID: 6970042
[TBL] [Abstract][Full Text] [Related]
16. Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.
Basch CM; Spitler LE; Engleman EG; Engleman EP
J Rheumatol; 1977; 4(4):377-88. PubMed ID: 604477
[TBL] [Abstract][Full Text] [Related]
17. [Suppressor T-lymphocytes in continuously progressive juvenile schizophrenia].
Maznina TP; Mikheeva TV; Lavrov VF; Abramova LI; Koliaskina GI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):1065-9. PubMed ID: 6236659
[TBL] [Abstract][Full Text] [Related]
18. Levamisole in the treatment of Hodgkin's disease.
Berényi E; Kávai M; Szabolcsi M; Szegedi G
Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte populations in chronic active liver disease: in vitro effect of levamisole on T-lymphocyte populations.
Pozsonyi T; Fehér J; Jakab L
Allergol Immunopathol (Madr); 1981; 9(1):37-44. PubMed ID: 6973266
[TBL] [Abstract][Full Text] [Related]
20. Suppressor cel activity of ferritin-bearing lymphocytes in patients with breast cancer.
Moroz C; Kupfer B
Isr J Med Sci; 1981; 17(9-10):879-81. PubMed ID: 6458580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
